skip to main content

S. 2260: Opioids and STOP Pain Initiative Act

A bill to establish and fund an Opioids and STOP Initiative to expand, intensify, and coordinate fundamental, translational, and clinical research of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain.

The bill’s titles are written by its sponsor.

Brian Schatz

Sponsor. Senior Senator for Hawaii. Democrat.

Read Text »
Last Updated: Dec 21, 2017
Length: 8 pages

Dec 21, 2017


Introduced on Dec 21, 2017

This bill is in the first stage of the legislative process. It was introduced into Congress on December 21, 2017. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.


3% chance of being enacted according to Skopos Labs (details)


Dec 21, 2017

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Ordered Reported

Passed Senate (House next)

Passed House

Signed by the President

S. 2260 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 2260 — 115th Congress: Opioids and STOP Pain Initiative Act.” 2017. January 16, 2018 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.